Rare Diseases: Genetic Testing and Targeted Therapy
|
|
- Noel Patrick
- 7 years ago
- Views:
Transcription
1 Rare Diseases: Genetic Testing and Targeted Therapy Meral Özgüç Hacettepe University Faculty of Medicine Department of Medical Biology & DNA/Cell Bank
2 RDs Definition! Low prevalence (Less than 5/10000)! ~30 M EU, ~30 M USA, ~250 M worldwide patients! diseases! Many unknown genes, no therapy for most RDs! 80% genetic background- all Mendelian disorders are rare! Rare cancers and infectious diseases
3 Classification! Lack of specific codes in international classification systems! Only 500 RDs in the WHO - ICD-10! Lack of interoperability between individual databases Hum Mutat 2012; 33:
4 Challenges in RDs! Timely and accurate diagnosis! Lack of information and experience in the healthcare system! Fragmented research! Slow drug development and treatments! Limited number of patients for clinical trials
5 Delay in Diagnosis In a group of RDs, 25% of patients waited for 5 to 30 for a diagnosis and initial diagnosis was wrong in 40% of the cases (EURORDIS 2007)
6 Governance Rare diseases is a priority area where global approach and multinational strategies is needed Together for Health: A Strategic Approach for the EU ! National Plans for Rare Diseases! IRDiRC-International Rare Diseases Research Consortium, 2012 (EU-NIH) Cooperation and coordination in RDs research Vision to develop 200 new therapies and diagnose most RDs
7 Road Map for Diagnosis Gene Identification! Candidate gene approach! Linkage analysis - large families with multiple affecteds! Homozygosity mapping -consanguineous families, AR Mendelian diseases! Whole exom sequencing (WES) - only protein coding regions! Whole genome sequencing (WGS)
8 Biobanks are essential infrastructures for family collections for gene identification V:18 V:19 V:25 V:26 VI:15 VI:16 VI:17 VI:18 VI:19 VI:20 VI:21 VI:22 VI:25 VI:27 VI:28 VII:1 VII:3 VII:4 VII:5
9 GENETIC TESTING Genetic testing is testing for variations in germline DNA sequences, or for products/effects arising from changes in heritable sequences, which are predictive of significant health effects. OECD! Diagnostic Testing! Newborn Screening! Carrier detection! Presemptomatic Testing! Predictive Testing! Pharmacogenetics
10 Genetic Testing in Rare Diseases Identification of the genetic variation in the causative gene Assessment of the phenotype Confirmation of diagnosis Counseling and therapy *Today ~2000 genetic tests are available for rare diseases *Genomic Testing. Fact Sheet: Identifying Opportunities to Improve Health and Transform Healthcare. CDC 24/7.
11 Bottlenecks in Designing Genetic Tests! One gene - one universal mutation - sickle cell anemia! Ethnic groups - Tay Sachs (Ashkenazi Jews) Mutation Frequency 1278insTATC ~82% IVS12 +1 ~15% 99% G269S ~2% *Data from the International TSD Data Collection Network, 2007
12 Bottlenecks in Designing Genetic Tests! Phenotypic heterogeneity many gene variants-single phenotype different mutations-same gene-different phenotypes LGMD mutations at more than 50 loci have been reported, making accurate diagnosis and genetic counseling a challenge Gene Reviews 2012! Modifiers MBL (Mannose Binding Lectin) protein is a possible modulator of CF (Cystic Fibrosis) phenotype Glycobiology 2011; 21;3: Dominant modifier DFNM1 suppresses recessive deafness DFNB26 Nature Genetics 2000; 26:
13 Next Generation Technologies Advantages of whole genome sequencing (WGS)! Identification of de novo mutations in dominant monogenic diseases Nature Reviews 2012; 13: ! Identification of de novo mutations in common diseases Nat Genetics 2011; 43: ! Identification of variations in noncoding regions that may affect the expression of the disease phenotype The Encyclopedia of DNA Elements (ENCODE) Consortium
14 Next Generation Biobanks! Human Biobanks and Genetic Research Databases are structured resources. and which include: (a) human biological materials and/or information generated from the analysis of the same; and (b) extensive associated information. (OECD)! Keepers of WGS data for future clinical use
15 Whole Genome Sequencing From data to clinical application Association of the allele with human pathology! model organisms,! biochemical studies,! in silico algorithms,! patient derived ips cells Nature Reviews 2013; 14:
16 WGS Newborn Screening A new NIH Programme Hundreds of US babies will be pioneers in genomic medicine through a US$ 25 million programme to sequence their genomes soon after they are born Nature News Blog 04 Sep 2013
17 Genomics Medicine Personalised Medicine Personal omics profiles Data management and clinical bioinformatics Disease description at cellular and molecular level Understand biological mechanisms Patient stratification Deep phenotyping * Targeted therapy *Hum Mutat 2012; 33:
18 Orphan Drug Policies! Orphan Drug Act 1983, USA! EMA - Committee for Orphan Medicinal Products, 2000! Creating Hope Act 2010 Bill Priority Review Voucher System to Rare Pediatric Diseases
19 Therapy for RDs! Pharmaceutical drugs! Diet restriction - PKU! Vitamins as cofactors! Suppression of toxicity Wilson s Disease (copper accumulation)
20 Therapy for RDs Advance products for therapy! Monogenic protein replacement therapies (MPRT) *(88% approval for clinical trials)! Cell and gene therapy products! Oligonucleotides! Fusion proteins! Monoclonal antibodies *Sci Transl Med 2013; 5: 178fs10.
21 Targeting the Cause of Disease (CF) I II III IV V No synthesis Block in processing Block in regulation Altered conductance Reduced synthesis G542X, R553X, W1282X, R1162X, 621-1G T, G A, 1078DT, 3659DC DF508, DI507, N1303K, S549N VX-809 Corrector G551D, R560T Kalydeco (Ivacaftor) Potentiator R117H, R334W, G85E, R347P KbC T, G A, A455E
22 From Research to Genetic Test in the Healthcare Environment! Decrease in cost/ increase in resolution! Decrease in sample size and non invasive techniques (prenatal diagnosis) cell free DNA in maternal blood! Turn-around time of the test! High quality sample (biobank)! Clinical bioinformatics/literacy in data interpretation
23 Rare Disorders Provide Insight for Common Disorders Type I Gaucher s Disease (GD) patients (Deficient glucocerebrosidase (GBA) gene) share clinical features similar to Parkinson patients (PD-GBA phenotype) Cell Metabolism 2013; 17:
24 RARE DISORDERS COMMON DISORDERS Bridging the gap
25 Education for all in the PPPM Era! Public! Funding agencies! Healthcare providers! Nurses and genetic counsellers! Funding agencies! Ethics review committees Genomics divide between countries: capacity building activities to aid diagnosis and management is required (Consanguinity belt countries - high prevalence of AR monogenic diseases)
26 Acknowledgements Prof. Dr. Meral Özgüç Hacettepe Rare Diseases Study Groups Department of Medical Biology, Center for Biological Resources and Genomics, Departments of Pediatrics and Internal Medicine Department of Medical Genetics, Department of Pathology
27 References! Katsanis SH, Katsanis N. Molecular genetic testing and the future of clinical genomics. Nature Reviews 2013; 14: ! O Roak BJ, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011; 43: ! Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nature Reviews 2012; 13: ! Riazuddin S, et al. Dominant modifier DFNM1 suppresses recessive deafness DFNB26. Nature Genetics 2000; 26: ! Genomic Testing. Fact Sheet: Identifying Opportunities to Improve Health and Transform Healtcare. CDC 24/7.! Gilissen C, et al. Unlocking Mendelian disease using exome sequencing. Genome Biology 2011; 12: 228! Robinson PN. Deep Phenotyping for Precision Medicine. Hum Mutat 2012; 33: ! Rath A, et al. Representation of Rare Diseases in Health Information Systems: The Orphanet Approach to Serve a Wide Range of End Users. Hum Mutat 2012; 33: ! Salari K. The Dawning Era of Personalized Medicine Exposes a Gap in Medical Education. PLoS Medicine 2009; 6(8): e ! Crunkhorn S. Enhanced chance of success for protein replacement therapies. Sci Transl Med 2013; 5: 178fs10.! Osellame LD, et al. Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease-Links to Parkinson s Disease. Cell Metabolism 2013; 17:
28 ! Forman J, et al. The need for worldwide policy and action plans for rare diseases. Acta Paediatrica 2012; 101; ! 2012 Report on the state of the art of rare disease activities in Europe of the European Union Committee of Experts on rare diseases. Part IV: European Medicines Agency Activities and Other European Activities in the Field of Rare Diseases.! Auffraf C, et al. Genome Medicine: past, present and future. Genome Medicine 2011; 3: 6.! Kong A, et al. Rate of de novo mutations and the importance of father s age to disease risk. Nature 2012; 488: ! Sifferlin A. Single Genetic Glitch May Explain Most Allergies and Asthma. Asthma & Allergies.! Ledford H. Drug bests cystic-fibrosis mutation. Nature 2012; 482: 145.! Van Goor F, et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A 2011; 108(46): ! Chalmers JD, et al.impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis. Glycobiology 2011;21(3):271-82! Pegoraro E, Hoffman EP. Limb-Girdle Muscular Dystrophy Overview. Gene Reviews 2000 Jun 08 [updated 2012 Aug 30]! Nature News Blog 04 Sep 2013! References
Genetic Testing in Research & Healthcare
We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes
More informationGenetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association
6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising
More informationInformation for patients and the public and patient information about DNA / Biobanking across Europe
Information for patients and the public and patient information about DNA / Biobanking across Europe BIOBANKING / DNA BANKING SUMMARY: A biobank is a store of human biological material, used for the purposes
More informationGenetic diagnostics the gateway to personalized medicine
Micronova 20.11.2012 Genetic diagnostics the gateway to personalized medicine Kristiina Assoc. professor, Director of Genetic Department HUSLAB, Helsinki University Central Hospital The Human Genome Packed
More informationLessons Learned from Carrier Screening: Cystic Fibrosis The Parent s s Perspective
Lessons Learned from Carrier Screening: Cystic Fibrosis The Parent s s Perspective Martin Kharrazi, Ph.D. Genetic Disease Screening Program California Department of Public Health Population-based Carrier
More informationEuropean registered Clinical Laboratory Geneticist (ErCLG) Core curriculum
(February 2015; updated from paper issued by the European Society of Human Genetics Ad hoc committee for the accreditation of clinical laboratory geneticists, published in February 2012) Speciality Profile
More informationWhat Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives
What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives What does the career involve? Explore family histories to identify risks Reducing risks
More informationGene mutation and molecular medicine Chapter 15
Gene mutation and molecular medicine Chapter 15 Lecture Objectives What Are Mutations? How Are DNA Molecules and Mutations Analyzed? How Do Defective Proteins Lead to Diseases? What DNA Changes Lead to
More informationThe NeurOmics team at a recent project meeting
Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work
More informationPatient Information. for Childhood
Patient Information Genetic Testing for Childhood Hearing Loss Introduction This document describes the most common genetic cause of childhood hearing loss and explains the role of genetic testing. Childhood
More informationThis fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive.
11111 This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive. In summary Genes contain the instructions for
More informationHuman Genome Organization: An Update. Genome Organization: An Update
Human Genome Organization: An Update Genome Organization: An Update Highlights of Human Genome Project Timetable Proposed in 1990 as 3 billion dollar joint venture between DOE and NIH with 15 year completion
More informationTitle: Genetics and Hearing Loss: Clinical and Molecular Characteristics
Session # : 46 Day/Time: Friday, May 1, 2015, 1:00 4:00 pm Title: Genetics and Hearing Loss: Clinical and Molecular Characteristics Presenter: Kathleen S. Arnos, PhD, Gallaudet University This presentation
More informationMolecular Genetic Testing in Public Health and Clinical Settings
Molecular Genetic Testing in Public Health and Clinical Settings Ira M. Lubin, PhD, FACMG Division of Laboratory Systems NCPDCID, CCID Centers for Disease Control and Prevention Atlanta, Georgia Disclaimers
More informationThe National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
More informationPreimplantation Genetic Diagnosis. Evaluation for single gene disorders
Preimplantation Genetic Diagnosis Evaluation for single gene disorders What is Preimplantation Genetic Diagnosis? Preimplantation genetic diagnosis or PGD is a technology that allows genetic testing of
More informationOverview of Genetic Testing and Screening
Integrating Genetics into Your Practice Webinar Series Overview of Genetic Testing and Screening Genetic testing is an important tool in the screening and diagnosis of many conditions. New technology is
More informationGene Therapy and Genetic Counseling. Chapter 20
Gene Therapy and Genetic Counseling Chapter 20 What is Gene Therapy? Treating a disease by replacing, manipulating or supplementing a gene The act of changing an individual s DNA sequence to fix a non-functional
More informationCarrier Screening For Genetic Diseases Preconception Consent (Female and/or Male Partner)
Carrier Screening For Genetic Diseases Preconception Consent (Female and/or Male Partner) The goal of our practice at ARMS is to make sure that you receive optimal care to improve your chances of having
More informationRevision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices Response from Cancer Research UK to the Commission August 2010 1. Cancer Research UK (CR-UK) 1 is leading the world in finding
More informationTRACKS GENETIC EPIDEMIOLOGY
Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that
More informationOptional Tests Offered Before and During Pregnancy
Plano Women s Healthcare Optional Tests Offered Before and During Pregnancy Alpha-Fetoprotein Test (AFP) and Quad Screen These are screening tests that can assess your baby s risk of having such birth
More informationLecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)
Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs) Single nucleotide polymorphisms or SNPs (pronounced "snips") are DNA sequence variations that occur
More informationSummary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs
Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer
More informationMendelian inheritance and the
Mendelian inheritance and the most common genetic diseases Cornelia Schubert, MD, University of Goettingen, Dept. Human Genetics EUPRIM-Net course Genetics, Immunology and Breeding Mangement German Primate
More informationSummary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor)
EMA/662624/2015 Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor) This is a summary of the risk management plan (RMP) for Orkambi, which details the measures to be taken
More informationMCB41: Second Midterm Spring 2009
MCB41: Second Midterm Spring 2009 Before you start, print your name and student identification number (S.I.D) at the top of each page. There are 7 pages including this page. You will have 50 minutes for
More informationPersonalized medicine in China s healthcare system
Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL
More informationEURORDIS-NORD-CORD Joint Declaration of. 10 Key Principles for. Rare Disease Patient Registries
EURORDIS-NORD-CORD Joint Declaration of 10 Key Principles for Rare Disease Patient Registries 1. Patient Registries should be recognised as a global priority in the field of Rare Diseases. 2. Rare Disease
More informationCystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program
Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Introduction: Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and
More informationA leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
More informationITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
More informationSchool of Nursing. Presented by Yvette Conley, PhD
Presented by Yvette Conley, PhD What we will cover during this webcast: Briefly discuss the approaches introduced in the paper: Genome Sequencing Genome Wide Association Studies Epigenomics Gene Expression
More informationGenetic Testing: Scientific Background for Policymakers
Genetic Testing: Scientific Background for Policymakers Amanda K. Sarata Specialist in Health Policy December 19, 2011 CRS Report for Congress Prepared for Members and Committees of Congress Congressional
More informationYour newborn baby s blood test
Newborn Screening Free health checks for your baby Your newborn baby s blood test The Newborn Metabolic Screening Programme All babies are checked at birth to see that all is well. Some of your baby s
More informationProspects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS
Prospects for Vaccines against Hepatitis C Viruses T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS HCV Vaccine Prevention strategies Protective immunity Barriers and solutions Vaccine candidates
More informationInsurance. Chapter 7. Introduction
65 Chapter 7 Insurance Introduction 7.1 The subject of genetic screening in relation to insurance is not new. In 1935 R A Fisher addressed the International Congress of Life Assurance Medicine on the topic,
More informationGenomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
More informationInnovation Platform: Sudden Cardiac Death
Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration
More informationTherapeutic Goods Administration Orphan Drugs Program: Discussion paper
Therapeutic Goods Administration Orphan Drugs Program: Discussion paper Submission from the Clinical Oncology Society of Australia and Cancer Council Australia March 2015 The Clinical Oncology Society
More informationMinimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics January 2006 1. BACKGROUND ICSI has been shown to be effective for male factor infertility and it also
More informationHeritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait
TWINS AND GENETICS TWINS Heritability: Twin Studies Twin studies are often used to assess genetic effects on variation in a trait Comparing MZ/DZ twins can give evidence for genetic and/or environmental
More informationSickle cell anemia: Altered beta chain Single AA change (#6 Glu to Val) Consequence: Protein polymerizes Change in RBC shape ---> phenotypes
Protein Structure Polypeptide: Protein: Therefore: Example: Single chain of amino acids 1 or more polypeptide chains All polypeptides are proteins Some proteins contain >1 polypeptide Hemoglobin (O 2 binding
More informationAbout The Causes of Hearing Loss
About 1 in 500 infants is born with or develops hearing loss during early childhood. Hearing loss has many causes: some are genetic (that is, caused by a baby s genes) or non-genetic (such as certain infections
More informationGenetic Disorder Brochure Project
Genetic Disorder Brochure Project (modified from a project found on the Robbinsdale School District website) Overview Create a tri-fold brochure for a doctor s office waiting room. The brochure should
More informationHow does genetic testing work?
How does genetic testing work? What is a genetic test? A genetic test looks at to find changes (variants) that cause disease or put you at greater risk to develop disease. DNA is the code our bodies use
More informationBIOSCIENCES COURSE TITLE AWARD
COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,
More informationObstetrical Ultrasound and Prenatal Diagnostic Center
Obstetrical Ultrasound and Prenatal Diagnostic Center Prenatal Diagnosis: Options and Opportunities Learn about various screening options including Early Risk Assessment (ERA), now available to women of
More informationIMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS 29 OCTOBER 2015 DR. DIRK J. EVERS BACKGROUND TreatmentMAP
More informationRoche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
More informationX Linked Inheritance
X Linked Inheritance Information for Patients and Families 2 X linked Inheritance The following will give you information about what X linked inheritance means and how X linked conditions are inherited.
More informationDr Alexander Henzing
Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander
More informationDigital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:
More informationGenetic Mutations Cause Many Birth Defects:
Genetic Mutations Cause Many Birth Defects: What We Learned from the FORGE Canada Project Jan M. Friedman, MD, PhD University it of British Columbia Vancouver, Canada I have no conflicts of interest related
More informationACRONIM : InNerMeD-I-Network. STARTING DATE: 2013-04-01 DURATION (in months): 30. PRIORITY AREA: Actions under the second objective 'Promote health'
IInherriitted NeuRoMettabolliic Diiseases IINFORMATIION NETWORK ACRONIM : InNerMeD-I-Network STARTING DATE: 2013-04-01 DURATION (in months): 30 PRIORITY AREA: Actions under the second objective 'Promote
More informationGenetic Mutations. Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes.
Genetic Mutations Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes. Agenda Warm UP: What is a mutation? Body cell? Gamete? Notes on Mutations Karyotype Web Activity
More informationDNA Sequencing and Personalised Medicine
DNA Sequencing and Personalised Medicine Mick Watson Director of ARK-Genomics The Roslin Institute PERSONALISED MEDICINE What is personalised medicine? Personalized Medicine refers to the tailoring of
More informationMarrying a relative. Is there an increased chance that a child will have genetic problems if its parents are related to each other?
Marrying a relative Is there an increased chance that a child will have genetic problems if its parents are related to each other? The simple answer to this question is Yes, there is an increased chance.
More informationB R U C E K. L I N, M P H B E C O M I N G A M O M / C O M E N Z A N D O B I E N T R A I N I N G J A N U A R Y 1 4, 2 0 1 3 3 4 5 P M
Understanding the Importance of Your Family Health History B R U C E K. L I N, M P H B E C O M I N G A M O M / C O M E N Z A N D O B I E N T R A I N I N G J A N U A R Y 1 4, 2 0 1 3 3 4 5 P M Disclosures
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. Service Commissioner Lead Provider Lead Period Date of Review E01/Sb NHS Genomic Laboratory Services 1. Population Needs 1.1
More informationUNIT 13 (OPTION) Genetic Abnormalities
Unit 13 Genetic Abnormailities 1 UNIT 13 (OPTION) Genetic Abnormalities Originally developed by: Hildur Helgedottir RN, MN Revised (2000) by: Marlene Reimer RN, PhD, CCN (C) Associate Professor Faculty
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 11.11.2008 COM(2008) 679 final COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE
More informationIl ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020
Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020 Lucia Monaco Horizon 2020 Advisory Group, Societal Challenges 1: Health, Demographic Change and Wellbeing Seminario:
More informationARMENIA. Albert Matevosyan MD,PhD
Albert Matevosyan MD,PhD Neurohereditary Diseases Charity Association Head of Republic Center of Medical Genetic and Department of Medical Genetic Yerevan State Medical University Rome EUROPLAN (Italy)
More informationAttacking the Biobank Bottleneck
Attacking the Biobank Bottleneck Professor Jan-Eric Litton BBMRI-ERIC BBMRI-ERIC Big Data meets research biobanking Big data is high-volume, high-velocity and highvariety information assets that demand
More informationERA-Net COFUND Research Programmes on Rare Diseases (E-RARE)
Bologna 15 Dicembre 2014 ERA-Net COFUND Research Programmes on Rare Diseases (E-RARE) The Role of RER-ASSR Antonio Addis Research Governance Area Agenzia Sanitaria e Sociale Regionale How do Regions might
More informationThe Human Genome Project. From genome to health From human genome to other genomes and to gene function Structural Genomics initiative
The Human Genome Project From genome to health From human genome to other genomes and to gene function Structural Genomics initiative June 2000 What is the Human Genome Project? U.S. govt. project coordinated
More informationThe Future of the Electronic Health Record. Gerry Higgins, Ph.D., Johns Hopkins
The Future of the Electronic Health Record Gerry Higgins, Ph.D., Johns Hopkins Topics to be covered Near Term Opportunities: Commercial, Usability, Unification of different applications. OMICS : The patient
More informationMEDICAL GENETICS GENERAL OBJECTIVE SPECIFIC OBJECTIVES
SUBJECT MEDICAL GENETICS CREDITS Total: 4.5 Theory 2.5 Practical 2 GENERAL OBJECTIVE To provide students with terminology and knowledge from the field of human genetics that will enable them to understand
More informationThe Liver and Alpha-1. Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION
The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION What Is Alpha-1 Antitrypsin Deficiency? Alpha-1 is a condition that may result in serious lung disease in adults and/or liver
More informationFACULTY OF MEDICAL SCIENCE
Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern
More informationGENOMICS: REINVIGORATING THE FIELD OF PSYCHIATRIC RESEARCH
Office of Communications www.broadinstitute.org T 617-714-7151 communications@broadinstitute.org 7 Cambridge Center, Cambridge, MA 02142 GENOMICS: REINVIGORATING THE FIELD OF PSYCHIATRIC RESEARCH For decades,
More information1 ALPHA-1. The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) FOUNDATION FOUNDATION. A patient s guide to Alpha-1 liver disease
The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people
More informationGENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110
GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic
More informationVision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort
More informationBiochemistry Major Talk 2014-15. Welcome!!!!!!!!!!!!!!
Biochemistry Major Talk 2014-15 August 14, 2015 Department of Biochemistry The University of Hong Kong Welcome!!!!!!!!!!!!!! Introduction to Biochemistry A four-minute video: http://www.youtube.com/watch?v=tpbamzq_pue&l
More informationBI122 Introduction to Human Genetics, Fall 2014
BI122 Introduction to Human Genetics, Fall 2014 Course Overview We will explore 1) the genetic and molecular basis of heredity and inherited traits, 2) how genetics & genomics reveals an understanding
More informationThe Developing Person Through the Life Span 8e by Kathleen Stassen Berger
The Developing Person Through the Life Span 8e by Kathleen Stassen Berger Chapter 3 Heredity and Environment PowerPoint Slides developed by Martin Wolfger and Michael James Ivy Tech Community College-Bloomington
More informationRegulatory Issues in Genetic Testing and Targeted Drug Development
Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types
More informationThe 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
More informationBiology 1406 Exam 4 Notes Cell Division and Genetics Ch. 8, 9
Biology 1406 Exam 4 Notes Cell Division and Genetics Ch. 8, 9 Ch. 8 Cell Division Cells divide to produce new cells must pass genetic information to new cells - What process of DNA allows this? Two types
More informationGuidelines for health professionals about DNA / Biobanking in Europe
Guidelines for health professionals about DNA / Biobanking in Europe BIOBANKING SUMMARY A "biobank" is a: "service unit, non-profit organization for the collection and preservation of biological material
More informationInformation leaflet. Centrum voor Medische Genetica. Version 1/20150504 Design by Ben Caljon, UZ Brussel. Universitair Ziekenhuis Brussel
Information on genome-wide genetic testing Array Comparative Genomic Hybridization (array CGH) Single Nucleotide Polymorphism array (SNP array) Massive Parallel Sequencing (MPS) Version 120150504 Design
More informationThe RCGP Curriculum: Clinical Modules
The RCGP Curriculum: Clinical Modules Version approved 18 May 2015 for implementation from 5 August 2015 3.02 Genetics in Primary Care Summary It has been estimated that at least one in ten of the patients
More informationPage 1. Genetic Testing and Breast Cancer by Zales and Colosi
Genetic Testing and Breast Cancer: Is a Little Knowledge a Dangerous Thing? by Charlotte R. Zales, Education Department, Moravian College, Bethlehem, PA and Joseph C. Colosi, Biology Department, DeSales
More informationDelivering the power of the world s most successful genomics platform
Delivering the power of the world s most successful genomics platform NextCODE Health is bringing the full power of the world s largest and most successful genomics platform to everyday clinical care NextCODE
More informationEDITORIAL MINING FOR GOLD : CAPITALISING ON DATA TO TRANSFORM DRUG DEVELOPMENT. A Changing Industry. What Is Big Data?
EDITORIAL : VOL 14 ISSUE 1 BSLR 3 Much has been written about the potential of data mining big data to transform drug development, reduce uncertainty, facilitate more targeted drug discovery and make more
More informationPopulation Genetics and Multifactorial Inheritance 2002
Population Genetics and Multifactorial Inheritance 2002 Consanguinity Genetic drift Founder effect Selection Mutation rate Polymorphism Balanced polymorphism Hardy-Weinberg Equilibrium Hardy-Weinberg Equilibrium
More informationAutomated DNA sequencing 20/12/2009. Next Generation Sequencing
DNA sequencing the beginnings Ghent University (Fiers et al) pioneers sequencing first complete gene (1972) first complete genome (1976) Next Generation Sequencing Fred Sanger develops dideoxy sequencing
More informationDIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES
DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES Extracts from a review article by KN North and KJ Jones: Recent advances in diagnosis of the childhood muscular dystrophies Journal of Paediatrics and Child Health
More informationGENETIC COUNSELING IS IT A CAREER FOR YOU? Judith L Miller, MS, LGC April 8, 2014
GENETIC COUNSELING IS IT A CAREER FOR YOU? Judith L Miller, MS, LGC April 8, 2014 What is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives. Most
More informationCommunicating with Families about Family History and Genetics
Communicating with Families about Family History and Genetics Abdallah F. Elias, M.D. Providence Genetics Clinic at Grant Creek & Florence Family Practice Department of Biomedical and Pharmaceutical Sciences
More informationBachelor of Science in Applied Bioengineering
Bachelor of Science in Applied Bioengineering Applied bioengineering employs scientific and engineering principles to process biological materials from biological agents for provision of goods and related
More informationClinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
More informationCourse outline. Code: BIM202 Title: Genes in Health and Disease
Course outline Code: BIM202 Title: Genes in Health and Disease Faculty of: Science, Health, Education and Engineering Teaching Session: Semester 1 Year: 2015 Course Coordinator: Dr Anna Kuballa Tel: (07)
More informationSequencing and microarrays for genome analysis: complementary rather than competing?
Sequencing and microarrays for genome analysis: complementary rather than competing? Simon Hughes, Richard Capper, Sandra Lam and Nicole Sparkes Introduction The human genome is comprised of more than
More informationTargeted. sequencing solutions. Accurate, scalable, fast TARGETED
Targeted TARGETED Sequencing sequencing solutions Accurate, scalable, fast Sequencing for every lab, every budget, every application Ion Torrent semiconductor sequencing Ion Torrent technology has pioneered
More informationThe correct answer is c A. Answer a is incorrect. The white-eye gene must be recessive since heterozygous females have red eyes.
1. Why is the white-eye phenotype always observed in males carrying the white-eye allele? a. Because the trait is dominant b. Because the trait is recessive c. Because the allele is located on the X chromosome
More informationPUBLIC HEALTH IMPROVEMENT PARTNERSHIP
PUBLIC HEALTH IMPROVEMENT PARTNERSHIP PUBLIC HEALTH ACTIVITIES & SERVICES INVENTORY TECHNICAL NOTES HEALTHY FAMILY DEVELOPMENT Nurse-Family Partnership Nurse-Family Partnership is a voluntary program of
More information